Thumbnail Image
Publication

Carboplatin (CB) combined with oral or intravenous (IV) etoposide (ET) for advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): real-world findings from two European neuroendocrine tumour society centres of excellence

Frizziero, Melissa
; 
Spada, Francesca
; 
Lamarca, Angela
; 
Kordatou, Zoe
; 
Barriuso, Jorge
; 
Nuttall, Christina
; 
McNamara, Mairead G
; ; 
Mansoor, Was
; 
Manoharan, Prakash
... show 2 more
Citations
Altmetric:
Abstract
Authors
Frizziero, Melissa
Spada, Francesca
Lamarca, Angela
Kordatou, Zoe
Barriuso, Jorge
Nuttall, Christina
McNamara, Mairead G
Hubner, Richard A
Mansoor, Was
Manoharan, Prakash
Fazio, N
Valle, Juan W
Affiliation
Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK
Description
Date
2018
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 90.88 KB
Keywords
Type
Meetings and Proceedings
Citation
Frizziero M, Spada F, Lamarca A, Kordatou Z, Barriuso J, Nuttall C, et al. 1318PCarboplatin (CB) combined with oral or intravenous (IV) etoposide (ET) for advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): real-world findings from two European neuroendocrine tumour society centres of excellence. Ann Oncol. 2018;29(suppl_8):472.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/621810
Embedded videos